Why You Should Be Annotating

Scientists who rely on accurate gene predictions should share in the burden of creating them

Written byJeffrey M. Perkel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Your local convenience store probably has a dish filled with pennies near the checkout. If your order costs $1.01 and you don't have a penny, you take one. The next time you're in, if you get change, you're expected to leave a penny. Unfortunately, when it comes to annotating sequence databases, it seems most researchers are the type to take a penny, but not give one back.

With the click of a mouse, scientists gain free access to enormously expensive and annotated sequence databases, the product of teams of researchers and informaticians. Yet when users notice errors in annotation - gene models that don't match their own data, for instance - they generally keep the knowledge to themselves. "There's a certain amount of apathy," says WormBase developer Lincoln Stein. "People realize a gene model is incorrect but they don't report it."

They don't alert database curators to new gene models ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies